NCT04292561

Brief Summary

Delirium is an acute onset of attentional and cognitive impairment. BIS guided anesthesia can reduce the incidence of postoperative delirium. Long term electroencephalogram (EEG) suppression during operation is related to postoperative delirium. The latest research shows that the anesthesia depth guided by EEG does not reduce the incidence of postoperative delirium. The purpose of this study was to explore the relationship between anesthesia exposure with different minimum alveolar concentration(MAC) and postoperative delirium(POD), and to observe the characteristics of EEG.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
460

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 8, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

March 1, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 3, 2020

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2023

Completed
11 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 10, 2023

Completed
Last Updated

February 24, 2023

Status Verified

March 1, 2022

Enrollment Period

2.9 years

First QC Date

January 8, 2020

Last Update Submit

February 23, 2023

Conditions

Outcome Measures

Primary Outcomes (5)

  • Incidence of POD

    Incidence of POD after surgery

    The 1st day after the surgery

  • Incidence of POD

    Incidence of POD after surgery

    The 2nd day after the surgery

  • Incidence of POD

    Incidence of POD after surgery

    The 3rd day after the surgery

  • Incidence of POD

    Incidence of POD after surgery

    The 5th day after the surgery

  • Incidence of POD

    Incidence of POD after surgery

    The 7th day after the surgery

Secondary Outcomes (5)

  • EEG burst inhibition

    During surgery

  • EEG burst inhibition

    During surgery

  • Incidence of adverse events

    30-day after surgery

  • length of stay

    From 1st day after the surgery to 2 weeks

  • 30-day mortality

    30-day after surgery

Study Arms (2)

light general anesthesia

EXPERIMENTAL

During anesthesia maintenance, patients were received with low concentration sevoflurane to maintain a target of 0.8 MAC.

Drug: Low MAC

deep general anesthesia

EXPERIMENTAL

During anesthesia maintenance, patients were received with high concentration sevoflurane to maintain a target of 1.0 MAC.

Drug: High MAC

Interventions

To maintain a target of sevoflurane inhalation concentration 0.8 MAC.

light general anesthesia

To maintain a target of sevoflurane inhalation concentration 1.0 MAC.

deep general anesthesia

Eligibility Criteria

Age60 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of gastrointestinal diseases
  • Patients were aged 60 to 90 years
  • American Society of Anesthesiologists (ASA) risk classification II-IV
  • Patients were scheduled to undergo elective major abdominal operation(with a anticipated time of 2-6 h)

You may not qualify if:

  • Preoperative dementia or cognitive impairment
  • Mental instability or mental illness
  • Patients with any factors affecting cognitive assessment, such as language, vision and hearing impairment
  • Any cerebrovascular accident occurred within 3 months, such as stroke etc
  • Previous history of delirium
  • Known hypersensitivity to sevoflurane or history of malignant hyperthermia
  • Abuse of narcotic sedative and analgesic drugs
  • Those who have reoperation within 7 days after operation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital of Anhui Medical University

Hefei, Anhui, 230022, China

Location

Related Publications (5)

  • Chaput AJ, Bryson GL. Postoperative delirium: risk factors and management: continuing professional development. Can J Anaesth. 2012 Mar;59(3):304-20. doi: 10.1007/s12630-011-9658-4. Epub 2012 Feb 4. English, French.

    PMID: 22311257BACKGROUND
  • Chan MT, Cheng BC, Lee TM, Gin T; CODA Trial Group. BIS-guided anesthesia decreases postoperative delirium and cognitive decline. J Neurosurg Anesthesiol. 2013 Jan;25(1):33-42. doi: 10.1097/ANA.0b013e3182712fba.

    PMID: 23027226BACKGROUND
  • Fritz BA, Kalarickal PL, Maybrier HR, Muench MR, Dearth D, Chen Y, Escallier KE, Ben Abdallah A, Lin N, Avidan MS. Intraoperative Electroencephalogram Suppression Predicts Postoperative Delirium. Anesth Analg. 2016 Jan;122(1):234-42. doi: 10.1213/ANE.0000000000000989.

    PMID: 26418126BACKGROUND
  • Wildes TS, Mickle AM, Ben Abdallah A, Maybrier HR, Oberhaus J, Budelier TP, Kronzer A, McKinnon SL, Park D, Torres BA, Graetz TJ, Emmert DA, Palanca BJ, Goswami S, Jordan K, Lin N, Fritz BA, Stevens TW, Jacobsohn E, Schmitt EM, Inouye SK, Stark S, Lenze EJ, Avidan MS; ENGAGES Research Group. Effect of Electroencephalography-Guided Anesthetic Administration on Postoperative Delirium Among Older Adults Undergoing Major Surgery: The ENGAGES Randomized Clinical Trial. JAMA. 2019 Feb 5;321(5):473-483. doi: 10.1001/jama.2018.22005.

    PMID: 30721296BACKGROUND
  • Ridaura V, Belkaid Y. Gut microbiota: the link to your second brain. Cell. 2015 Apr 9;161(2):193-4. doi: 10.1016/j.cell.2015.03.033.

    PMID: 25860600BACKGROUND

MeSH Terms

Conditions

Emergence Delirium

Condition Hierarchy (Ancestors)

DeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsNeurocognitive DisordersMental Disorders

Study Officials

  • Xuesheng Liu, MD.PHD

    The First Affiliated Hospital of Anhui Medical University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 8, 2020

First Posted

March 3, 2020

Study Start

March 1, 2020

Primary Completion

January 30, 2023

Study Completion

February 10, 2023

Last Updated

February 24, 2023

Record last verified: 2022-03

Locations